Literature DB >> 819429

Demonstration of pyroglutamylpeptidase and amidase activities toward thyrotropin-releasing hormone in hamster hypothalamus extracts.

C Prasad, A Peterkofsky.   

Abstract

Using a radioimmunoassay method for thyrotropin-releasing hormone, the presence of thyrotropin-releasing hormone-metabolizing activity in various hamster tissues was demonstrated. While there was substantial activity degrading thyrotropin-releasing hormone in hypothalamus, there was a notable absence of such activity in pituitary. The enzymatic activity in the hypothalamus was shown to be soluble and separable into two fractions. Analysis of the metabolic products formed by the two enzymes indicated that one possessed an amidase activity (less than Glu-His-Pro-NH2 leads to less than Glu-His-Pro) and the other possessed pyroglutamylpeptidase activity (less than Glu-His-Pro-NH2 leads to less than Glu+His-Pro-NH2). Other peptides containing NH2-terminal pyroglutamic acid or COOH-terminal amide groups did not block the hydrolysis of thyrotropin-releasing hormone, suggesting that the enzymes were specific. Some inhibitors preferentially blocked the activity of one or the other enzymes. Of possible biological significance is the observation that thyroid-stimulating hormone inhibited the amidase activity while hydrocortisone inhibited the pyroglutamylpeptidase activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 819429

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Enzyme inhibitors of marine microbial origin with pharmaceutical importance.

Authors:  Chiaki Imada
Journal:  Mar Biotechnol (NY)       Date:  2004-05-06       Impact factor: 3.619

2.  On the mechanism of fasting-associated elevations in hypothalamic cyclo(His-Pro) content.

Authors:  C Prasad; T Iriuchijima; R M Edwards; J F Wilber; M Mori; D J Rogers
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

3.  Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma.

Authors:  J Møss; H Bundgaard
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

4.  Evidence for pyroglutamyl peptidase I and prolyl endopeptidase activities in the rat insulinoma cell line RINm 5F: lack of relationship with TRH metabolism.

Authors:  P Salers; L H Ouafik; P Giraud; A Dutour; J Y Maltese; C Oliver
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

Review 5.  Is all cyclo(His-Pro) derived from thyrotropin-releasing hormone?

Authors:  C Prasad; A Jayaraman; H J Robertson; J K Rao
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

6.  Hypothalamic portal blood immunoreactive TRH in the rat: lack of effect of hypothyroidism and thyroid hormone treatment.

Authors:  M C Ching; R D Utiger
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

7.  Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.

Authors:  Carolyn L Fisher; Ross J Resnick; Soumya De; Lucila A Acevedo; Kun Ping Lu; Frank C Schroeder; Linda K Nicholson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Thyrotropin-releasing hormone (TRH) uptake in intestinal brush-border membrane vesicles: comparison with proton-coupled dipeptide and Na(+)-coupled glucose transport.

Authors:  D T Thwaites; N L Simmons; B H Hirst
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

9.  Preparation of Yeast Hydrolysate Enriched in Cyclo-His-Pro (CHP) by Enzymatic Hydrolysis and Evaluation of Its Functionality.

Authors:  Hyun Jung Lee; Heung Soo Son; Chung Park; Hyung Joo Suh
Journal:  Prev Nutr Food Sci       Date:  2015-12-31

10.  Developmental changes in the distribution of rat brain pyroglutamate aminopeptidase, a possible determinant of endogenous cyclo(His-Pro) concentrations.

Authors:  C Prasad; M Mori; W Pierson; J F Wilber; R M Ewards
Journal:  Neurochem Res       Date:  1983-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.